These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 352258)

  • 1. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.
    Grasso S; Meinardi G; de Carneri I; Tamassia V
    Antimicrob Agents Chemother; 1978 Apr; 13(4):570-6. PubMed ID: 352258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between antibacterial activity of some cephalosporins and pharmacokinetic properties "in vitro" (author's transl)].
    Tamassia V; Meinardi G; Grasso S; de Carneri I
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():785-92. PubMed ID: 400257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].
    Ratschow R; Krone JR
    Infection; 1977; 5(4):236-41. PubMed ID: 340385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Timed bacteriostatic and bactericidal activities of cefmetazole against selected gram-negative bacteria].
    Masuda G; Young C; Negishi M; Watanabe T; Yamazaki E; Motegi K
    Jpn J Antibiot; 1982 Sep; 35(9):2288-92. PubMed ID: 6754988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.
    Goto S; Sakamoto H; Ogawa M; Tsuji A; Kuwahara S
    Chemotherapy; 1982; 28(1):18-25. PubMed ID: 7035088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.
    Murakawa T; Sakamoto H; Hirose T; Nishida M
    Antimicrob Agents Chemother; 1980 Sep; 18(3):377-81. PubMed ID: 6999984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
    Wagenvoort JH; Brus-Weijer L; Michel MF
    Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y
    J Antibiot (Tokyo); 1970 Mar; 23(3):137-48. PubMed ID: 4394125
    [No Abstract]   [Full Text] [Related]  

  • 11. Bactericidal activity of cephalosporins in an in vitro model simulating serum levels.
    Nishida M; Murakawa T; Kamimura T; Okada N
    Antimicrob Agents Chemother; 1978 Jul; 14(1):6-12. PubMed ID: 356725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth curves of enterobacteriaceae and the estimation of L-forms under the influence of cephalosporin antibiotics.
    Ullmann U
    Zentralbl Bakteriol Orig A; 1977 Jun; 238(2):220-7. PubMed ID: 329618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity and induction of cell volume alterations of cephalosporins in Escherichia coli.
    Schulz E; von Klitzing L; Sack K; Marre R
    Chemotherapy; 1985; 31(6):425-32. PubMed ID: 3908008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro model for monitoring bacterial responses to antibiotic agents under simulated in vivo conditions.
    Bergan T; Carlsen IB; Fuglesang JE
    Infection; 1980; Suppl 1():096-10. PubMed ID: 6772578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimicrobial activity and human pharmacology of cephalexin, a new orally absorbed cephalosporin C antibiotic.
    Thornhill TS; Levison ME; Johnson WD; Kaye D
    Appl Microbiol; 1969 Mar; 17(3):457-61. PubMed ID: 4388601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.
    Odsbu I; Khedkar S; Lind F; Khedkar U; Nerkar SS; Orsini N; Tamhankar AJ; Stålsby Lundborg C
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29351236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins.
    Bauernfeind A
    Infection; 1990; 18(1):48-52. PubMed ID: 2179138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antibiotics eliminated by first order kinetics.
    Bergan T; Carlsen IB
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():147-52. PubMed ID: 3980326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
    Sader HS; Hsiung A; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):341-4. PubMed ID: 17141461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity and pharmacology of cefazolin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1973 Oct; 4(4):396-401. PubMed ID: 4598612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.